UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline

Journal of clinical oncology, 2012-08, Vol.30 (23), p.2912-2918

2012

Link zum Volltext

Verfügbarkeit prüfen

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2823-2830

2009

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Journal of clinical oncology, 2004-01, Vol.22 (1), p.77-85

2004

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2101-2107

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2034-2039

2008

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801

Journal of clinical oncology, 2001-05, Vol.19 (9), p.2370-2380

2001

Link zum Volltext

Verfügbarkeit prüfen

Durable Complete Responses With High-Dose Bolus Interleukin-2 in Patients With Metastatic Melanoma Who Have Experienced Progression After Biochemotherapy

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3802-3807

2007

Link zum Volltext

Verfügbarkeit prüfen

Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: A brief technical report

International journal of radiation oncology, biology, physics, 2004-12, Vol.60 (5), p.1419-1424

2004

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral Epidermal Growth Factor Receptor Antisense DNA Therapy in Head and Neck Cancer: First Human Application and Potential Antitumor Mechanisms

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1235-1242

2009

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Interferon Alfa-2b Does Not Diminish Antibody Response to GM2 Vaccination in Patients With Resected Melanoma: Results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1430-1436

2001

Link zum Volltext

Verfügbarkeit prüfen

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)

European journal of cancer (1990), 2011-07, Vol.47 (10), p.1476-1483

2011

Link zum Volltext

Verfügbarkeit prüfen

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)

European journal of cancer (1990), 2009-07, Vol.45 (10), p.1807-1814

2009

Link zum Volltext

Verfügbarkeit prüfen

Current experience with CTLA4-blocking monoclonal antibodies for the treatment of solid tumors

Journal of immunotherapy, 2010-07, Vol.33 (6), p.557-569

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2745-2751

1999

Link zum Volltext

Verfügbarkeit prüfen

An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2014-06, Vol.73 (6), p.1241-1252

2014

Link zum Volltext

Verfügbarkeit prüfen

Radiosurgery for the treatment of spinal melanoma metastases

Stereotactic and functional neurosurgery, 2005-01, Vol.83 (5-6), p.213

2005

Link zum Volltext

Verfügbarkeit prüfen

New applications of cancer immunotherapy

Seminars in oncology, 2002-06, Vol.29 (3), p.1-4

Agarwala, Sanjiv S

2002

Link zum Volltext

Verfügbarkeit prüfen

The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma

Supportive care in cancer, 2003-05, Vol.11 (5), p.304-312

2003

Link zum Volltext

Verfügbarkeit prüfen

Results from a randomized phase III study comparing Combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma

Journal of clinical oncology, 2002, Vol.20 (1), p.125-133

2002

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy in head and neck cancer

Hematology/oncology clinics of North America, 1999-08, Vol.13 (4), p.743

Agarwala, S S

1999

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant interferon treatment for melanoma

Hematology/oncology clinics of North America, 1998-08, Vol.12 (4), p.823

1998

Link zum Volltext

Verfügbarkeit prüfen

Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma: A Report From the 11715 Study Group

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2178-2185

2008

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms and Management of Toxicities Associated With High-Dose Interferon Alfa-2b Therapy

Journal of clinical oncology, 2002-09, Vol.20 (17), p.3703-3718

2002

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival

International journal of radiation oncology, biology, physics, 1998-10, Vol.42 (3), p.581-589

1998

Link zum Volltext

Verfügbarkeit prüfen

Gamma knife radiosurgery in the management of malignant melanoma brain metastases

Neurosurgery, 2007-03, Vol.60 (3), p.471-482

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(27)
Humans
(27)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Oncology
(22)
Female
(21)
Male
(20)
Middle Aged
(19)
Adult
(18)
Aged
(18)
Melanoma - Drug Therapy
(15)
Pharmacology. Drug Treatments
(15)
Tumors
(15)
Antineoplastic Agents
(11)
Aged, 80 And Over
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Melanoma - Pathology
(8)
Skin Neoplasms - Drug Therapy
(8)
Melanoma - Secondary
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study

Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma

High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801

Durable Complete Responses With High-Dose Bolus Interleukin-2 in Patients With Metastatic Melanoma Who Have Experienced Progression After Biochemotherapy

Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: A brief technical report

Intratumoral Epidermal Growth Factor Receptor Antisense DNA Therapy in Head and Neck Cancer: First Human Application and Potential Antitumor Mechanisms

High-Dose Interferon Alfa-2b Does Not Diminish Antibody Response to GM2 Vaccination in Patients With Resected Melanoma: Results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)

Current experience with CTLA4-blocking monoclonal antibodies for the treatment of solid tumors

Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma

An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors

Radiosurgery for the treatment of spinal melanoma metastases

New applications of cancer immunotherapy

The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma

Results from a randomized phase III study comparing Combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma

Adjuvant chemotherapy in head and neck cancer

Adjuvant interferon treatment for melanoma

Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma: A Report From the 11715 Study Group

Mechanisms and Management of Toxicities Associated With High-Dose Interferon Alfa-2b Therapy

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival

Gamma knife radiosurgery in the management of malignant melanoma brain metastases

Aktive Filter

Suchergebnisse filtern